GARRISON BRADFORD & ASSOCIATES INC - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 11 filers reported holding Novozymes A/S in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GARRISON BRADFORD & ASSOCIATES INC ownership history of Novozymes A/S
ValueSharesWeighting
Q1 2019$603,000
-10.8%
13,100
-13.2%
0.51%
-16.4%
Q4 2018$676,000
-18.3%
15,1000.0%0.61%
-8.3%
Q3 2018$827,000
+8.7%
15,1000.0%0.67%
+6.7%
Q2 2018$761,000
-3.7%
15,1000.0%0.62%
-7.1%
Q1 2018$790,000
-8.4%
15,1000.0%0.67%
-5.8%
Q4 2017$862,000
+10.9%
15,1000.0%0.71%
+9.7%
Q3 2017$777,000
+17.4%
15,1000.0%0.65%
+13.4%
Q2 2017$662,000
+10.5%
15,1000.0%0.57%
+8.3%
Q1 2017$599,000
+15.0%
15,1000.0%0.53%
+10.2%
Q4 2016$521,000
-22.2%
15,1000.0%0.48%
-23.9%
Q3 2016$670,000
-7.7%
15,1000.0%0.63%
-11.4%
Q2 2016$726,000
+7.2%
15,1000.0%0.71%
-9.6%
Q1 2016$677,000
-6.1%
15,1000.0%0.79%
-2.5%
Q4 2015$721,000
+38.7%
15,100
+25.8%
0.81%
+40.8%
Q3 2015$520,000
-8.8%
12,0000.0%0.57%
+3.1%
Q2 2015$570,000
+4.0%
12,0000.0%0.56%
+8.8%
Q1 2015$548,000
+8.3%
12,0000.0%0.51%
+11.5%
Q4 2014$506,000
-2.5%
12,0000.0%0.46%
-11.6%
Q3 2014$519,000
-13.9%
12,0000.0%0.52%
-7.5%
Q2 2014$603,000
+14.2%
12,0000.0%0.56%
+10.2%
Q1 2014$528,000
+4.1%
12,0000.0%0.51%
+6.3%
Q4 2013$507,000
+10.2%
12,0000.0%0.48%
+1.7%
Q3 2013$460,000
+19.5%
12,0000.0%0.47%
+13.8%
Q2 2013$385,00012,0000.41%
Other shareholders
Novozymes A/S shareholders Q4 2015
NameSharesValueWeighting ↓
Lenox Wealth Management, Inc. 62,488$2,907,0000.87%
ZEVIN ASSET MANAGEMENT LLC 34,899$1,624,0000.52%
HIGH POINTE CAPITAL MANAGEMENT LLC 5,090$238,0000.33%
BOSTON FINANCIAL MANGEMENT LLC 108,846$5,065,0000.29%
Moloney Securities Asset Management, LLC 15,263$713,0000.24%
Boston Common Asset Management, LLC 24,577$1,148,0000.14%
Hemenway Trust Co LLC 12,125$564,0000.09%
Renaissance Investment Group LLC 5,000$234,0000.09%
QUADRANT CAPITAL GROUP LLC 5,748$263,0000.04%
Douglass Winthrop Advisors, LLC 6,902$321,0000.01%
View complete list of Novozymes A/S shareholders